Subcutaneous injections of the MG3 insulin-loaded nanogel (4 IU kg/BW) as well as native insulin at a dose of 2.5 IU kg/BW were administered to T1D rodents. The gene discussed is INS; the disease is type 1 diabetes mellitus.